VNDA (Vanda Pharmaceuticals) הכנסות חזויות של החברה

Vanda Pharmaceuticals restores the brain's neurochemical balance, as confirmed by the future sales volume trend on the GURU.Markets base chart, where the current parameter is 0.23. Business protection is ensured by drug patents and strict FDA control. Stability is further enhanced by compliance with environmental standards for chemical disposal and the digitalization of office processes.

Vanda Pharmaceuticals' development of drugs for neurological disorders generates a steady cash flow, which serves as the base for extrapolating future cash inflows in the calculation of this indicator. By comparing market forecasts with actual revenue, GURU.Markets identifies deviations in the business's fundamental value through the company's forward-looking sales dynamics, allowing investors to promptly assess capital drawdown risks or the potential for operational expansion.